Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alexander Bodkin

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Human Psychopharmacology|June 17, 2011
Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorderJ Alexander Bodkin, Christer Allgulander, Pierre M Llorca, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 30, 2019
Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorderMichael E Thase, Arielle D Stanford, Asli Memisoglu, et al.
The American Journal of Psychiatry|February 13, 2016
Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled TrialMaurizio Fava, Asli Memisoglu, Michael E Thase, et al.
Schizophrenia Bulletin|March 25, 2017
Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric ControlsCharity J Morgan, Michael J Coleman, Ayse Ulgen, et al.
Schizophrenia Bulletin|March 22, 2015
Quantitative Measures of Craniofacial Dysmorphology in a Family Study of Schizophrenia and Bipolar IllnessCurtis K Deutsch, Deborah L Levy, Selya F R Price, et al.
Schizophrenia Research|December 1, 2009
Tailoring the definition of the clinical schizophrenia phenotype in linkage studiesVerena Krause, Olga Krastoshevsky, Michael J Coleman, et al.
The Journal of Nervous and Mental Disease|June 2, 2012
Psychiatric treatment of the VIP: some paradoxical risksBenjamin C Silverman, Alice Asby, David H Brendel, et al.
Biological Psychiatry|July 8, 2019
Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase GeneJ Alexander Bodkin, Michael J Coleman, Laura J Godfrey, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Human Psychopharmacology|June 17, 2011
Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorderJ Alexander Bodkin, Christer Allgulander, Pierre M Llorca, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 30, 2019
Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorderMichael E Thase, Arielle D Stanford, Asli Memisoglu, et al.
The American Journal of Psychiatry|February 13, 2016
Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled TrialMaurizio Fava, Asli Memisoglu, Michael E Thase, et al.
Schizophrenia Bulletin|March 25, 2017
Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric ControlsCharity J Morgan, Michael J Coleman, Ayse Ulgen, et al.
Schizophrenia Bulletin|March 22, 2015
Quantitative Measures of Craniofacial Dysmorphology in a Family Study of Schizophrenia and Bipolar IllnessCurtis K Deutsch, Deborah L Levy, Selya F R Price, et al.
Schizophrenia Research|December 1, 2009
Tailoring the definition of the clinical schizophrenia phenotype in linkage studiesVerena Krause, Olga Krastoshevsky, Michael J Coleman, et al.
The Journal of Nervous and Mental Disease|June 2, 2012
Psychiatric treatment of the VIP: some paradoxical risksBenjamin C Silverman, Alice Asby, David H Brendel, et al.
Biological Psychiatry|July 8, 2019
Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase GeneJ Alexander Bodkin, Michael J Coleman, Laura J Godfrey, et al.
Pageof 2